Page last updated: 2024-11-06

thymidine and Carcinoma, Medullary

thymidine has been researched along with Carcinoma, Medullary in 2 studies

Carcinoma, Medullary: A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lazaretti-Castro, M1
Grauer, A1
Baier, R1
Vieira, JG1
Ziegler, R1
Raue, F1
Zatelli, MC1
Tagliati, F1
Taylor, JE1
Rossi, R1
Culler, MD1
degli Uberti, EC1

Other Studies

2 other studies available for thymidine and Carcinoma, Medullary

ArticleYear
1,25-Dihydroxyvitamin D3 stimulates growth and inhibits calcitonin secretion in a human C cell carcinoma cell line.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1995, Volume: 28, Issue:9

    Topics: Calcitonin; Calcitriol; Carcinoma, Medullary; Cell Division; Humans; In Vitro Techniques; Thymidine;

1995
Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:5

    Topics: Carcinoma, Medullary; Cell Division; Humans; Oligopeptides; Peptides, Cyclic; Piperazines; Receptors

2001